Woman out for a jog

Committed to Improving the Lives of Patients with Diabetes

vTv is a clinical stage biotechnology company with a pipeline of drug candidates led by TTP399, a potentially transformative treatment for the reduction of hypoglycemic episodes in type 1 diabetes patients. To learn more about our science please visit our pipeline page.